Moderna Forecasts COVID Sales Decline As Costs Rise, Shares Fall
Moderna Inc on Thursday forecast declining COVID-19 vaccine sales and rising costs for 2023, raising concerns the U.S.
Source: ibtimes.com
Stay updated with breaking news from Michael Yee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Moderna Inc on Thursday forecast declining COVID-19 vaccine sales and rising costs for 2023, raising concerns the U.S.
BIIB earnings call for the period ending December 31, 2022.
VRTX earnings call for the period ending December 31, 2022.
GILD earnings call for the period ending December 31, 2022.
Operator: Good afternoon. Thank you for attending today's Fourth Quarter and Full Year 2022 Gilead Sciences Earnings Conference Call. My name is Henna, and I will be your moderator for today's call.